Ensysce Biosciences Inc (ENSC)
0.541
-0.03
(-5.25%)
USD |
NASDAQ |
Apr 22, 16:00
0.535
-0.01
(-1.11%)
After-Hours: 20:00
Ensysce Biosciences Market Cap: 3.965M for April 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 3.965M |
| April 19, 2024 | 4.185M |
| April 18, 2024 | 4.252M |
| April 17, 2024 | 4.616M |
| April 16, 2024 | 4.732M |
| April 15, 2024 | 4.980M |
| April 12, 2024 | 5.460M |
| April 11, 2024 | 5.524M |
| April 10, 2024 | 5.734M |
| April 09, 2024 | 5.717M |
| April 08, 2024 | 5.717M |
| April 05, 2024 | 5.90M |
| April 04, 2024 | 6.178M |
| April 03, 2024 | 5.882M |
| April 02, 2024 | 5.937M |
| April 01, 2024 | 5.717M |
| March 28, 2024 | 5.792M |
| March 27, 2024 | 5.863M |
| March 26, 2024 | 6.003M |
| March 25, 2024 | 5.852M |
| March 22, 2024 | 5.856M |
| March 21, 2024 | 5.724M |
| March 20, 2024 | 5.90M |
| March 19, 2024 | 6.084M |
| March 18, 2024 | 5.937M |
| Date | Value |
|---|---|
| March 15, 2024 | 5.816M |
| March 14, 2024 | 5.497M |
| March 13, 2024 | 5.497M |
| March 12, 2024 | 5.372M |
| March 11, 2024 | 5.622M |
| March 08, 2024 | 5.755M |
| March 07, 2024 | 2.473M |
| March 06, 2024 | 2.502M |
| March 05, 2024 | 2.530M |
| March 04, 2024 | 2.346M |
| March 01, 2024 | 2.901M |
| February 29, 2024 | 2.933M |
| February 28, 2024 | 2.882M |
| February 27, 2024 | 2.769M |
| February 26, 2024 | 2.772M |
| February 23, 2024 | 2.80M |
| February 22, 2024 | 2.816M |
| February 21, 2024 | 2.926M |
| February 20, 2024 | 2.988M |
| February 16, 2024 | 2.923M |
| February 15, 2024 | 2.80M |
| February 14, 2024 | 2.832M |
| February 13, 2024 | 2.706M |
| February 12, 2024 | 3.587M |
| February 09, 2024 | 3.335M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.346M
Minimum
Mar 04 2024
351.83M
Maximum
Jul 02 2021
28.71M
Average
8.743M
Median
Market Cap Benchmarks
| Processa Pharmaceuticals Inc | 4.427M |
| Omeros Corp | 178.75M |
| Relmada Therapeutics Inc | 116.77M |
| NeuroBo Pharmaceuticals Inc | 15.31M |
| MAIA Biotechnology Inc | 46.51M |
Market Cap Related Metrics
| Price | 0.541 |
| Earnings Yield | -979.7% |